Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic modulation with acipimox in acute heart failure
2006-004485-14Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of acipimox in Acute Heart Failure (AHF) and heart failure (HF), sponsored by Aarhus University Hospital. Primary endpoints: myocardial glucose-extraction, myocardial free fatty acid-extraction and 2 more. Started Dec 2006; status: completed.
02
Drugs
acipimox
03
Conditions
Acute Heart Failure (AHF)heart failure (HF)
Beyond the preview
Go deeper on 2006-004485-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004485-14.